Patient, surgeon, and treatment characteristics associated with homologous blood transfusion requirement during radical retropubic prostatectomy: Multivariate nomogram to assist patient counseling

Urology

Volumn 64, Issue 1, 2004, Pages 117-122

  Dash, Atreya ^b   Dunn, Rodney L ^b   Resh, Jennifer ^b   Wei, John T ^b   Montie, James E ^b   Sanda, Martin G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; HORMONE;

ADULT; AGED; ANESTHESIA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER HORMONE THERAPY; CANCER PATIENT; CONTROLLED STUDY; DISEASE SEVERITY; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; PATIENT COUNSELING; PERIOPERATIVE PERIOD; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR;

ADENOCARCINOMA; AGED; ANESTHESIA; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CLINICAL COMPETENCE; COHORT STUDIES; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOADJUVANT THERAPY; NOMOGRAMS; ORGAN SIZE; PATIENTS; PHYSICIANS; PROBABILITY; PROSPECTIVE STUDIES; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 3042743258     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.02.018     Document Type: Article

References (25)

1. Reiner W.G., Walsh P.C. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol. 121:1979;198-200
2. Rainwater L.M., Segura J.W. Technical consideration in radical retropubic prostatectomy blood loss after ligation of dorsal venous complex. J Urol. 143:1990;1163-1165
3. Koch M.O., Smith J.A. Jr. Blood loss during radical retropubic prostatectomy is preoperative autologous blood donation indicated? J Urol. 156:1996;1077-1079
4. Shekarriz B., Upadhyay J., Wood D.P. Intraoperative, perioperative, and long-term complications of radical prostatectomy. Urol Clin North Am. 28:2001;639-653
5. Goldschlag B., Afzal N., Ballantine Carter H., et al. Is preoperative donation of autologous blood rational for radical retropubic prostatectomy? J Urol. 164:2000;1968-1972
6. Goh M., Celina G., Kleer P., et al. Autologous blood donation prior to anatomical radical retropubic prostatectomy is it necessary? Urology. 49:1997;569-573
7. Goad J.R., Eastham J.A., Fitzgerald K.B., et al. Radical retropubic prostatectomy limited benefit of autologous blood donation. J Urol. 154:1995;2103-2109
8. Monk T.G., Goodnough L.T., Brecher M.E., et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology. 91:1999;24-33
9. Goodnough L.T., Brecher M.E., Kanter M.H., et al. Transfusion medicine first of two parts - blood transfusion. N Engl J Med. 340:1999;438-447
10. Gilbert W.B., Smith J.A. Jr. Blood use strategies in urologic surgery. Urology. 55:2000;461-467
11. Mangano D.T., Browner W.S., Hollenberg M., et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery the study of Perioperative Ischemia Research Group. N Engl J Med. 323:1990;1781-1788
12. Hogue C.W. Jr, Goodnough L.T., Monk T.G. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion. 38:1998;924-931
13. Hollenbeck B.K., Dunn R.L., Wei J.T., et al. Determinants of long-term sexual HRQOL after radical prostatectomy measured by a validated instrument. J Urol. 169:2003;1453-1457
14. Terk M.D., Stock R.G., Stone N.N. Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol. 160:1998;1379-1382
15. Shir Y., Srinivasa N.R., Frank S., et al. Intraoperative blood loss during radical retropubic prostatectomy epidural versus general anesthesia. Urology. 45:1995;993-999
16. Abbas F., Scardino P.T. Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol Clin North Am. 23:1996;587-604
17. Fradet Y. The role of neoadjuvant androgen deprivation prior to radical prostatectomy. Urol Clin North Am. 23:1996;575-585
18. Soloway MS, Sharifi R, Wajsman Z, et al. for the Lupron Depot Neoadjuvant Prostate Cancer Study Group: Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. J Urol 154(2 Pt 1): 424-428, 1995
19. Ornstein D.K., Beiser J.A., Andriole G.L. Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer. BJU Int. 83:1999;43-46
20. Witjes WP, Schulman CC, and Debruyne FM, for the European Study Group on Neoadjuvant Treatment of Prostate Cancer: Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. Urology 49(3A suppl): 65-69, 1997
21. Hugosson J., Abrahamsson P.A., Ahlgren G., et al. The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment. Eur Urol. 29:1996;413-419
22. Sanda MG, and Montie JE: Prostate cancer - postoperative care, in Resnick MI, and Thompson I (Eds): Surgery of the Prostate. New York, Churchill Livingstone, 1997, pp 167-179
23. Begg C.B., Riedel E.R., Bach P.B., et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 346:2002;1138-1144
24. Hu J.C., Gold K.F., Pashos C.L., et al. The role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 21:2003;401-405
25. Barry M.J. Quality of life and prostate cancer treatment. (editorial) J Urol. 162:1999;407